Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas

Cancer

Volumn 109, Issue 3, 2007, Pages 510-517

  Miller, Eric A ^a,b   Keku, Temitope O ^b,c   Satia, Jessie A ^b,d   Martin, Christopher F ^b,c   Galanko, Joseph A ^c   Sandler, Robert S ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d University of North Carolina   (United States)

Author keywords

Adenoma; Calcium; Colorectal neoplasms; Fats; NSAID

Indexed keywords

CALCIUM; FAT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIETARY INTAKE; DRUG USE; FAT INTAKE; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL MODEL;

ADENOMA; ADENOMATOUS POLYPS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DIET; DIETARY FATS; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; VITAMIN D;

EID: 33846660047     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22453     Document Type: Article

References (48)

1. Wargovich MJ, Lynch PM, Levin B. Modulating effects of calcium in animal models of colon carcinogenesis and short-term studies in subjects at increased risk for colon cancer. Am J Clin Nutr. 1991;54(1 suppl):202S-205S.
2. Wargovich MJ, Allnutt D, Palmer C, Anaya P, Stephens LC. Inhibition of the promotional phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate: effect of simulating two human nutrient density levels. Cancer Lett. 1990;53:17-25.
3. Appleton GV, Davies PW, Bristol JB, Williamson RC. Inhibition of intestinal carcinogenesis by dietary supplementation with calcium. Br J Surg. 1987;74:523-525.
4. Pence BC, Dunn DM, Zhao C, Patel V, Hunter S, Landers M. Protective effects of calcium from nonfat dried milk against colon carcinogenesis in rats. Nutr Cancer. 1996;25:35-45.
5. Vinas-Salas J, Biendicho-Palau P, Pinol-Felis C, Miguelsanz-Garcia S, Perez-Holanda S. Calcium inhibits colon carcinogenesis in an experimental model in the rat. Eur J Cancer. 1998;34:1941-1945.
6. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 14 1999;340:101-107.
7. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000;356:1300-1306.
8. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis. 1988;9:187-190.
9. Hyman J, Baron JA, Dain BJ, et al. Dietary and supplemental calcium and the recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 1998;7:291-295.
10. De Stefani E, Mendilaharsu M, Deneo-Pellegrini H, Ronco A. Influence of dietary levels of fat, cholesterol, and calcium on colorectal cancer. Nutr Cancer. 1997;29:83-89.
11. Wallace K, Baron JA, Cole BF, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004;96:921-925.
12. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-899.
13. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348:883-890.
14. Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ. Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem. 1998;273:2424-2428.
15. DeRubertis FR, Craven PA, Saito R. Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products. J Clin Invest. 1984;74:1614-1624.
16. Xu XM, Sansores-Garcia L, Chen XM, Matijevic-Aleksic N, Du M, Wu KK. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA. 1999;96:5292-5297.
17. Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000;72:466-471.
18. Zittermann A, Sabatschus O, Jantzen S, et al. Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels compared with age-matched sedentary controls. Calcif Tissue Int. 2000;67:215-219.
19. Zittermann A, Sabatschus O, Jantzen S, Platen P, Danz A, Stehle P. Evidence for an acute rise of intestinal calcium absorption in response to aerobic exercise. Eur J Nutr. 2002;41:189-196.
20. Connelly AE, Satia-Abouta J, Martin CF et al. Vitamin C intake and apoptosis in normal rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2003;12:559-565.
21. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
22. Gerber AM, James SA, Ammerman AS, et al. Socioeconomic status and electrolyte intake in black adults: the Pitt County Study. Am J Public Health. 1991;81:1608-1612.
23. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 suppl):S498-504.
24. Blair SN, Haskell WL, Ho P, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 1985;122:794-804.
25. Richardson MT, Ainsworth BE, Jacobs DR, Leon AS. Validation of the Stanford 7-day recall to assess habitual physical activity. Ann Epidemiol. 2001;11:145-153.
26. Selvin S. Statistical Analysis of Epidemiologic Data, 2nd ed. New York: Oxford University Press; 1996.
27. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 1998;7:163-168.
28. Martinez ME, Marshall JR, Sampliner R, Wilkinson J, Alberts DS. Calcium, vitamin D, and risk of adenoma recurrence (United States). Cancer Causes Control. 2002;13:213-220.
29. Whelan RL, Horvath KD, Gleason NR, et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum. 1999;42:212-217.
30. Govers MJ, Termont DS, Lapre JA, Kleibeuker JH, Vonk RJ, Van der Meer R. Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res. 1996;56:3270-3275.
31. Newmark HL, Wargovich MJ, Bruce WR. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst. 1984;72:1323-1325.
32. Vander A, Sherman J, Luciano D. Human Physiology: the Mechanism of Body Function, 7th ed. New York: WCB/McGraw Hill; 1998.
33. Pence BC, Dunn DM, Zhao C, Landers M, Wargovich MJ. Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis. 1995;16:757-765.
34. Penman ID, Liang QL, Bode J, Eastwood MA, Arends MJ. Dietary calcium supplementation increases apoptosis in the distal murine colonic epithelium. J Clin Pathol. 2000;53:302-307.
35. ADA.A Primer on Fats and Oils. Available from URL: http://www.eatright. org/Public/NutritionInformation/92_9292.cfm Accessed on February 14, 2004.
36. Lin J, Zhang SM, Cook NR, Manson JE, Lee IM, Buring JE. Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol. 2005;161:755-764.
37. Peters U, Chatterjee N, McGlynn KA, et al. Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr. 2004;80:1358-1365.
38. Grau MV, Baron JA, Barry EL, et al. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005;14:2353-2358.
39. Boyapati SM, Bostick RM, McGlynn KA, et al. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal antiinflammatory drug use? Cancer Epidemiol Biomarkers Prev. 2003;12;631-637.
40. Peters U, McGlynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001;10:1267-1274.
41. Levine AJ, Harper JM, Ervin CM, et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 2001;39:35-41.
42. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003;95:1765-1771.
43. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control. 2001;12:607-614.
44. Platz EA, Hankinson SE, Hollis BW, et al. Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000;9:1059-1065.
45. Little J, Logan RF, Hawtin PG, Hardcastle JD, Turner ID. Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer. 1993;67:177-184.
46. Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX. Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer. 1993;55:213-219.
47. Macquart-Moulin G, Riboli E, Cornee J, Kaaks R, Berthezene P. Colorectal polyps and diet: a case-control study in Marseilles. Int J Cancer. 1987;40:179-188.
48. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-168.